Patent details
EP1506174 Title: USE OF NALTREXONE FOR TREATING KIDNEY AND LIVER DAMAGE
Basic Information
- Publication number:
- EP1506174
- PCT Application Number:
- PCT/US/2003/015461
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037289642
- PCT Publication Number:
- WO/2003/097608
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF NALTREXONE FOR TREATING KIDNEY AND LIVER DAMAGE
- French Title of Invention:
- UTILISATION DE LA NALTREXONE POUR LE TRAITEMENT DE LÉSIONS HÉPATIQUES ET RÉNALES
- German Title of Invention:
- VERWENDUNG VON NALTREXON ZUR BEHANDLUNG VON NIEREN- UND LEBERSCHÄDEN
- SPC Number:
Dates
- Filing date:
- 16/05/2003
- Grant date:
- 30/09/2015
- EP Publication Date:
- 30/09/2015
- PCT Publication Date:
- 27/11/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/02/2005
- EP B1 Publication Date:
- 30/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/05/2016
- Expiration date:
- 16/05/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/05/2003
- Name:
- Taiwanj Pharmaceuticals Co. Ltd.
- Address:
- 5, 362 Lane Chia Hsin Rd. Chu-Pei City, Hsinchu Country, Taiwan (TW)
Inventor
1
- Name:
- FAN Chin-Tsai
- Address:
- Taiwan (TW)
2
- Name:
- YEN Mao-Hsiung
- Address:
- Taiwan (TW)
Priority
- Priority Number:
- 380841 P
- Priority Date:
- 17/05/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/485;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|